Literature DB >> 25136770

Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.

Dechun Zheng1, Yunbin Chen1, Xiangyi Liu1, Ying Chen1, Luying Xu2, Wang Ren1, Weibo Chen3, Queenie Chan4.   

Abstract

PURPOSE: To prospectively evaluate the dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) value for predicting early nasopharyngeal carcinoma (NPC) chemoradiotherapy (CRT) response.
MATERIALS AND METHODS: Forty-two patients with advanced NPC were recruited and received three DCE-MRI exams before treatment (Pre-Tx), as well as 3 days (Day 3-Tx) and 40 days (Day 40-Tx) after chemotherapy initiation (two neoadjuvant chemotherapy cycles, NAC). We used DCE-Tool to measure primary tumor kinetic parameters (K(trans) , Kep , ve , and vp ) using the extended Tofts model. Kinetic parameters and corresponding changes were compared between responders and nonresponders after NAC or CRT treatment using Student's t or Mann-Whitney U tests.
RESULTS: Response to two NAC cycles correlated with short-term local control (P = 0.01). Compared to the nonresponder group, the responder group presented with significantly larger ΔK(trans) (0-3) , ΔKep(0-3) , and Δvp(0-3) values after NAC (P < 0.05). The complete response group after CRT exhibited significantly lower K(trans) (Day 40-Tx) and larger ΔK(trans) (0-3) values than the residual group (P = 0.05). High sensitivity (range: 74.1%-90%) and moderate-to-high specificity (range: 50%-84.3%) distinguished nonresponders from responders grouping after NAC or CRT, with diagnostic efficiency ranging from 69.3%-88%.
CONCLUSION: Our study showed kinetic parameter changes earlier after chemotherapy were potential markers for NPC patients receiving CRT therapy following NAC.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  DCE-MRI; nasopharyngeal carcinoma; neoadjuvant chemotherapy; radiation therapy; therapy response

Mesh:

Substances:

Year:  2014        PMID: 25136770     DOI: 10.1002/jmri.24723

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  17 in total

1.  Usefulness of dynamic contrast-enhanced magnetic resonance imaging for predicting treatment response to vinorelbine-cisplatin with or without recombinant human endostatin in bone metastasis of non-small cell lung cancer.

Authors:  Rui Zhang; Zhi-Yu Wang; Yue-Hua Li; Yao-Hong Lu; Shuai Wang; Wen-Xi Yu; Hui Zhao
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Quantitative Analysis of DCE-MRI and RESOLVE-DWI for Differentiating Nasopharyngeal Carcinoma from Nasopharyngeal Lymphoid Hyperplasia.

Authors:  J Y Yu; D Zhang; X L Huang; J Ma; C Yang; X J Li; H Xiong; B Zhou; R K Liao; Z Y Tang
Journal:  J Med Syst       Date:  2020-02-26       Impact factor: 4.460

3.  Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.

Authors:  Xiao-ping Yu; Jing Hou; Fei-ping Li; Wang Xiang; Qiang Lu; Yin Hu; Hui Wang
Journal:  Dentomaxillofac Radiol       Date:  2016-02-05       Impact factor: 2.419

4.  Radiomic analysis in T2W and SPAIR T2W MRI: predict treatment response to chemoradiotherapy in esophageal squamous cell carcinoma.

Authors:  Zhen Hou; Shuangshuang Li; Wei Ren; Juan Liu; Jing Yan; Suiren Wan
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

5.  Artificial Intelligence and Radiomics in Head and Neck Cancer Care: Opportunities, Mechanics, and Challenges.

Authors:  Lisanne V van Dijk; Clifton D Fuller
Journal:  Am Soc Clin Oncol Educ Book       Date:  2021-03

6.  MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma.

Authors:  Hao Xu; Jieke Liu; Ying Huang; Peng Zhou; Jing Ren
Journal:  Br J Radiol       Date:  2021-04-21       Impact factor: 3.629

7.  Multimodality functional imaging in radiation therapy planning: relationships between dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET.

Authors:  Moisés Mera Iglesias; David Aramburu Núñez; José Luis Del Olmo Claudio; Antonio López Medina; Iago Landesa-Vázquez; Francisco Salvador Gómez; Brandon Driscoll; Catherine Coolens; José L Alba Castro; Victor Muñoz
Journal:  Comput Math Methods Med       Date:  2015-02-19       Impact factor: 2.238

8.  DCE-MRI and IVIM-MRI of rabbit Vx2 tumors treated with MR-HIFU-induced mild hyperthermia.

Authors:  Mie K Lam; Chris Oerlemans; Martijn Froeling; Roel Deckers; Angelique D Barten-Van Rijbroek; Max A Viergever; Chrit T W Moonen; Clemens Bos; Lambertus W Bartels
Journal:  J Ther Ultrasound       Date:  2016-03-15

9.  Value of intravoxel incoherent motion and dynamic contrast-enhanced MRI for predicting the early and short-term responses to chemoradiotherapy in nasopharyngeal carcinoma.

Authors:  Jing Hou; Xiaoping Yu; Yin Hu; Feiping Li; Wang Xiang; Lanlan Wang; Hui Wang; Qiang Lu; Zhongping Zhang; Wenbin Zeng
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

10.  Low expression of Aldo-keto reductase 1B10 is a novel independent prognostic indicator for nasopharyngeal carcinoma.

Authors:  Yuanwei Guo; Weihao Luo; Zheng Hu; Jia Li; Xiaojie Li; Huiqiu Cao; Jun Li; Bo Wen; Jian Zhang; Hao Cheng; Wangyuan Guo; Tan Tan; Dixian Luo
Journal:  Cell Biosci       Date:  2016-03-05       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.